China NMPA Product Recall - LED blue light therapy device

The National Medical Products Administration (NMPA) announced on September 20, 2017, the voluntary recall of LED blue light therapy devices by Henan Ruichang Medical Device Manufacturing Co., Ltd. This action was taken after the company identified a critical non-conformance in a specific batch of its product, model RC-ZLY-01, manufactured on March 15, 2017, with factory numbers 2017031501-06. The primary violation involved the device's maximum total irradiance, which was found not to meet the established standard requirements. This deviation from prescribed specifications indicates a potential performance or safety issue that necessitated immediate attention. In response to this finding, Henan Ruichang Medical Device Manufacturing Co., Ltd. voluntarily initiated a Level III recall. This classification, as defined by the NMPA, signifies that while the product's use is unlikely to cause adverse health consequences, it still warrants corrective action to uphold product integrity and patient safety standards. The company's proactive recall underscores its commitment to regulatory compliance and quality assurance within the medical device industry under the NMPA's framework.